Latest BVF INC/IL Stock Portfolio
$3.57Billion– No. of Holdings #60
BVF INC/IL Performance:
2024 Q2: -5.19%YTD: -1.77%2023: 6.53%
Performance for 2024 Q2 is -5.19%, and YTD is -1.77%, and 2023 is 6.53%.
About BVF INC/IL and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, BVF INC/IL reported an equity portfolio of $3.6 Billions as of 30 Jun, 2024.
The top stock holdings of BVF INC/IL are MLTX, RVMD, KYMR. The fund has invested 26.8% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 6.5% of portfolio in REVOLUTION MEDICINES INC.
The fund managers got completely rid off SYNDAX PHARMACEUTICALS INC (SNDX), CIDARA THERAPEUTICS INC (CDTX) and DELCATH SYS INC (DCTH) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX), UNICYCIVE THERAPEUTICS INC (UNCY) and CYTOMX THERAPEUTICS INC (CTMX). BVF INC/IL opened new stock positions in AXSOME THERAPEUTICS INC (AXSM), CELCUITY INC (CELC) and AGIOS PHARMACEUTICALS INC (AGIO). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, 89BIO INC (ETNB) and CULLINAN THERAPEUTICS INC (CGEM).
The top stock holdings of BVF INC/IL are MLTX, RVMD, KYMR. The fund has invested 26.8% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 6.5% of portfolio in REVOLUTION MEDICINES INC.
The fund managers got completely rid off SYNDAX PHARMACEUTICALS INC (SNDX), CIDARA THERAPEUTICS INC (CDTX) and DELCATH SYS INC (DCTH) stocks. They significantly reduced their stock positions in JANUX THERAPEUTICS INC (JANX), UNICYCIVE THERAPEUTICS INC (UNCY) and CYTOMX THERAPEUTICS INC (CTMX). BVF INC/IL opened new stock positions in AXSOME THERAPEUTICS INC (AXSM), CELCUITY INC (CELC) and AGIOS PHARMACEUTICALS INC (AGIO). The fund showed a lot of confidence in some stocks as they added substantially to STRUCTURE THERAPEUTICS INC, 89BIO INC (ETNB) and CULLINAN THERAPEUTICS INC (CGEM).
BVF INC/IL Equity Portfolio Value
Last Reported on: 14 Aug, 2024
BVF INC/IL Annual Return Estimates Vs S&P 500
Our best estimate is that BVF INC/IL made a return of -5.19% in the last quarter. In trailing 12 months, it's portfolio return was 3.4%.
New Buys
| Ticker | $ Bought |
|---|---|
| axsome therapeutics inc | 76,877,500 |
| celcuity inc | 56,773,100 |
| agios pharmaceuticals inc | 51,317,400 |
| foghorn therapeutics inc | 30,486,500 |
| cidara therapeutics inc | 4,096,080 |
| pieris pharmaceuticals inc | 2,545,340 |
New stocks bought by BVF INC/IL
Additions
| Ticker | % Inc. |
|---|---|
| structure therapeutics inc | 206 |
| 89bio inc | 87.00 |
| cullinan therapeutics inc | 79.89 |
| eledon pharmaceuticals inc | 45.45 |
| ionis pharmaceuticals inc | 31.2 |
| ac immune sa | 29.26 |
| cg oncology inc | 28.32 |
| merus n v | 9.11 |
Additions to existing portfolio by BVF INC/IL
Reductions
| Ticker | % Reduced |
|---|---|
| janux therapeutics inc | -84.88 |
| unicycive therapeutics inc | -39.09 |
| cytomx therapeutics inc | -20.73 |
| galapagos nv | -15.79 |
| kura oncology inc | -14.71 |
| protagonist therapeutics inc | -11.63 |
BVF INC/IL reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| kronos bio inc | -3,776,560 |
| syndax pharmaceuticals inc | -44,625,000 |
| lexicon pharmaceuticals inc | -4,048,620 |
| an2 therapeutics inc | -4,028,280 |
| delcath sys inc | -5,733,860 |
| corvus pharmaceuticals inc | -643,303 |
| cidara therapeutics inc | -6,312,240 |
| pieris pharmaceuticals inc | -3,775,730 |
BVF INC/IL got rid off the above stocks
Sector Distribution
BVF INC/IL has about 85.3% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.3 |
| Others | 14.7 |
Market Cap. Distribution
BVF INC/IL has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 53.3 |
| SMALL-CAP | 22.9 |
| UNALLOCATED | 15.5 |
| MICRO-CAP | 7.9 |
Stocks belong to which Index?
About 47.4% of the stocks held by BVF INC/IL either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 52.6 |
| RUSSELL 2000 | 47.4 |
BVF INC/IL Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BVF INC/IL
BVF INC/IL has 60 stocks in it's portfolio. About 61% of the portfolio is in top 10 stocks. MLTX proved to be the most loss making stock for the portfolio. MIRM was the most profitable stock for BVF INC/IL last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGIO | agios pharmaceuticals inc | 1.44 | 1,190,110 | 51,317,400 | new | |||
| ALLK | allakos inc | 0.46 | 16,552,400 | 16,552,400 | unchanged | 0.00 | ||
| ANNX | annexon inc | 0.96 | 7,000,000 | 34,300,000 | unchanged | 0.00 | ||
| ANTX | an2 therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ASLN | aslan pharmaceuticals ltd | 0.01 | 1,050,000 | 315,000 | unchanged | 0.00 | ||
| AXSM | axsome therapeutics inc | 2.15 | 955,000 | 76,877,500 | new | |||
| CALT | calliditas therapeutics ab | 0.82 | 750,000 | 29,242,500 | unchanged | 0.00 | ||
| CDTX | cidara therapeutics inc | 0.12 | 343,055 | 4,096,080 | new | |||
| CDTX | cidara therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CELC | celcuity inc | 1.59 | 3,466,000 | 56,773,100 | new | |||
| CGEM | cullinan therapeutics inc | 2.81 | 5,750,680 | 100,292,000 | added | 79.89 | ||
| CRVS | corvus pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CTMX | cytomx therapeutics inc | 0.18 | 5,228,460 | 6,378,720 | reduced | -20.73 | ||
| DCTH | delcath sys inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ELDN | eledon pharmaceuticals inc | 0.47 | 6,293,280 | 16,614,300 | added | 45.45 | ||
| ELEV | elevation oncology inc | 0.17 | 2,312,200 | 6,242,940 | unchanged | 0.00 | ||
| EPIX | essa pharma inc | 1.29 | 8,748,630 | 46,017,800 | unchanged | 0.00 | ||
| ETNB | 89bio inc | 1.70 | 7,568,480 | 60,623,500 | added | 87.00 | ||
| FBRX | forte biosciences inc | 0.04 | 2,982,100 | 1,601,390 | unchanged | 0.00 | ||
| FDMT | 4d molecular therapeutics in | 2.31 | 3,922,410 | 82,331,400 | unchanged | 0.00 | ||